Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR Bio-Rad Laboratories Inc (BUWA.MU) Follow Add holdings 220.00 +2.00 +(0.92%) At close: April 25 at 8:17:20 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for BUWA.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: BUWA.MU View More All News Press Releases SEC Filings Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook? Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 Further weakness as Bio-Rad Laboratories (NYSE:BIO) drops 5.0% this week, taking three-year losses to 61% Should You Continue to Hold Bio-Rad Stock in Your Portfolio? Bio-Techne Opens New Customer Experience Centre in Germany Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate Alger Russell Innovation Index Updates for First Quarter 2025 Bio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60%